First humans test new Fungus-Fighting drug
NCT ID NCT02956499
Summary
This was the first study to test APX001 in people. Researchers gave the experimental drug to 80 healthy volunteers to check if it was safe and to see how the body processes it. The goal was to gather basic safety information before testing it in people who actually have fungal infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PRA Health Sciences
Groningen, 9728 NZ, Netherlands
-
PRA Health Sciences
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.